Region
Buy from your country's storefront
Nurosym serves UK and European markets; Nuropod serves the United States, Canada, Australia and New Zealand. The device is shared, but price, warranty handling and regulatory status follow the storefront.
A handheld electrical stimulation device with an ear electrode, sold by Parasym for guided daily use without an app or recurring subscription.
What it is
Nurosym is Parasym's non-invasive auricular vagus nerve stimulation device, which the company calls AVNT. A handheld controller drives an earpiece electrode placed on a specified outer-ear site, and the user sets a comfortable intensity for each daily session.
Parasym sells the same core device under two regional names: Nurosym through its UK and European storefronts, and Nuropod in the United States, Canada, Australia and New Zealand. The technology is shared; price, return terms, warranty handling and market authorization follow the storefront where you buy.
Nurosym is Parasym Ltd's ear-stimulation device, sold as Nuropod in some markets.
Nurosym markets its vagus-nerve stimulation device for lasting calm and more consistent energy.
Purchase cost
Current consumer price
Other Nurosym countries and the Nuropod storefront set their own currency and price.
Price and return terms are set per storefront; choose your country before comparing.
One-time kit price on the Ireland storefront; no app or recurring subscription is stated. Regional tax and shipping can differ.
Scope and pricing depend on the organization and market.
Ireland storefront and regional selector checked 31 August 2026; the selected storefront and checkout govern final price.
The consumer offer is one device kit; professional pages support healthcare, athlete and research inquiries.
A controller, ear electrode and supporting accessories.
Auricular electrical stimulation device
The kit includes the handheld controller, earpiece electrode, charger, guide and carry case; no paid subscription is stated.
Use only the specified ear placement and begin at a comfortable intensity under the current instructions.
Availability: available
Link verified
Information and inquiry access for professional settings.
Healthcare and research access
Resources and inquiry routes for healthcare, performance and research use.
Professional use, training and device status should be confirmed for the intended country and scope.
Availability: available
Link verified
For consumers
No app or recurring subscription is stated; regional tax and shipping can differ.
Use only the specified ear placement and begin at a comfortable intensity under the current instructions.
DevicePackage
For professionals
Scope and pricing depend on the organization and market. · Contact for terms · Nurosym for professionals: Contact for terms
Professional use, training and device status should be confirmed for the intended country and scope.
ServiceProfessional Service
Fit → adjust → complete a session
Correct ear placement and comfortable intensity are central to the device routine.
Read the current contraindications and seek clinical advice when an implanted device, pregnancy, heart condition or other listed issue applies.
Follow the illustrated instructions for the specified outer-ear placement rather than moving the electrode to another site.
Increase gradually until stimulation is perceptible but comfortable, following the current product guide.
Use the published session routine and note comfort or unexpected effects before repeating it.
Electrical stimulation + ear electrode
Nurosym delivers low-level electrical stimulation through an electrode placed on the outer ear.
Electrode
The earpiece targets a specified external-ear site associated with an auricular branch of the vagus nerve.
The placement illustrated in the Nurosym guide is specific to this earpiece.
Controller
The handheld device allows the user to increase or decrease stimulation within its programmed range.
Stronger sensation is not evidence of greater benefit and may reduce tolerability.
Routine
The current system is operated directly from the controller without an app or paid subscription.
Session controls are on the handheld unit.
Where + how to access
Country selection matters because Parasym sells the same core device under two regional names, each with its own storefront terms.
Publicly identified people
Parasym publicly connects Nurosym to its founders and clinical-science team.
Co-founder and chief executive
Publicly identified leader of Parasym.
Co-founder
Publicly associated with the company's founding and product development.
Clinical and scientific leadership
Named in current Nurosym clinical materials.
Clinical and scientific team
Named in current Nurosym clinical materials.
What the record shows
Parasym publishes human studies and a CE-certification statement. Its research library includes both studies of its own devices and wider vagus-nerve stimulation research.
The company states that Nurosym is CE certified and publishes a certification explainer.
Its evidence library includes randomized and prospective human research alongside wider neuromodulation literature.
The public certification page does not provide a complete certificate, notified-body record, device class and intended-purpose document for independent verification.
Some device-associated studies are small or single-group, and results should not be generalized beyond the studied population and protocol.
Nurosym's terms state that U.S. health claims have not been evaluated by the FDA. Confirm the product and regulatory status for your region before buying.
Independent coverage
Independent coverage has examined consumer vagus-nerve stimulation while noting the still-developing evidence base.
A useful outside view of the category and Nurosym experience.
BBC Science Focus
Independent coverage
Consumer feature
Decision guide
Region, suitability and the return clock are the practical checks before ordering.
Region
Nurosym serves UK and European markets; Nuropod serves the United States, Canada, Australia and New Zealand. The device is shared, but price, warranty handling and regulatory status follow the storefront.
Safety
Implanted electronic devices and other listed conditions can make unsupervised electrical stimulation unsuitable.
Returns
Nurosym allows a return request within 30 days after the device arrives, with return shipping paid by the customer. Nuropod's FAQ describes a 37-day window counted from the order.
Common questions
Transparency
Researched by Longevity.io
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint